Medical/Pharmaceuticals
Yingli Pharma Announces Successful End-of-Phase 2 Meeting with FDA and Clearance of Global Multi-center Phase 3 Registration Study Design of Linperlisib for the Treatment of Relapsed and/or Refractory Peripheral T-cell Lymphoma
SAN FRANCISCO, April 1, 2025 /PRNewswire/ -- Shanghai Yingli Pharmaceutical Co., Ltd. (Yingli Pharma), a clinical stage biotechnology company developing oral small molecule drugs for cancer, metabolic, and immune diseases, announced today that it has received clearance from the US Food and Drug A...
2025-04-01 22:00
3116
Senior Vice President at United Imaging Inducted to the AIMBE College of Fellows
HOUSTON, April 1, 2025 /PRNewswire/ -- United Imaging, a global manufacturer of modern medical imaging technology, is proud to announce thatLingzhi (Lance) Hu, Ph.D., Senior Vice President and Chief Technology Officer of United Imaging Research at United Imaging, has been inducted into the 2025 C...
2025-04-01 21:00
2356
Peijia Medical collaborates with dsm-firmenich to create groundbreaking innovative medical device products
SUZHOU, China, April 1, 2025 /PRNewswire/ -- Today, April 1st, Peijia Medical Technology (Suzhou) Co., Ltd. held a strategic innovation cooperation signing ceremony and a press conference to announce the research and development achievements of polymer heart valves using ultra-high molecular weig...
2025-04-01 20:00
3677
Dizal Announces DZD8586 and DZD6008 Presentations at 2025 ASCO Annual Meeting
SHANGHAI, April 1, 2025 /PRNewswire/ -- Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced today that results of its investigational drug candidatesDZD8586 and DZD6008, have been selected for pr...
2025-04-01 18:18
2830
PeptiGrowth Inc. is Launching a Novel Synthetic Peptide: KGF alternative peptide (FGFR2b agonist)
TOKYO, April 1, 2025 /PRNewswire/ -- PeptiGrowth Inc. (Headquarters: Chiyoda-ku, Tokyo, President: Junichiro Ishizuka) has successfully developed a novel synthetic peptide called "KGF alternative- peptide (FGFR2b agonist)" which is functionally equivalent to recombinant keratinocyte growth factor ...
2025-04-01 14:30
2452
ECHO IQ SIGNS STRATEGIC PARTNERSHIP AND INTEGRATION AGREEMENTS WITH SCIMAGE AND MEDAXIOM TO EXPAND ECHOSOLV AS ACROSS 36 US CARDIOLOGY NETWORKS
* EchoSolv AS will be fully integrated into ScImage's medical workflow platform, facilitating streamlined deployment within MedAxiom's hospital and cardiology networks. * ScImage is a nationally recognised Cloud and integrated workflow management platform, with over 1,200 users, specialisin...
2025-04-01 13:39
2864
Merck Exercised the Option for the Global Rights of Abbisko Therapeutics's Pimicotinib
SHANGHAI, March 31, 2025 /PRNewswire/ -- On April 1, 2025, Beijing Time, Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics") announced that Merck has exercised the global commercialization option for pimicotinib (ABSK021), with an option exercise fee ofUSD85.0 million, under the licensing agr...
2025-04-01 08:48
4591
Luye Pharma's Rivastigmine Twice Weekly Transdermal Patch Approved for Marketing in Japan for the Treatment of Alzheimer's Dementia
TOKYO, March 31, 2025 /PRNewswire/ -- Luye Pharma Group today announced that marketing approval for its innovative formulation Rivastigmine Twice Weekly Transdermal Patch has been granted by the Japanese Ministry of Health, Labour and Welfare as a new drug, indicated for suppression of progressio...
2025-03-31 21:35
3156
Lunit Announces Partnership with the National Cancer Institute to Advance AI-Powered Biomarker Research
Collaboration to apply Lunit's AI technologies across NCI's broad spectrum of cancer studies, aiming to accelerate personalized cancer care SEOUL, South Korea, March 31, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics...
2025-03-31 21:00
2597
Ascletis Announces Positive Interim Results from Its U.S. Phase Ib Trial with ASC30, a Potentially First-in-Class Subcutaneous Injection Small Molecule GLP-1R Agonist
-Ultra-long-acting subcutaneous (SQ) injection formulation of small molecule ASC30 demonstrated a 36-day half-life in patients with obesity, supporting once monthly or less frequent administration. -As previously disclosed, oral tablet formulation of small molecule ASC30 demonstrated potentially ...
2025-03-31 19:00
2719
Harbour BioMed Reports Full Year 2024 Financial Results
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 31, 2025 /PRNewswire/ -- Harbour BioMed ("HBM" or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology and oncology, today announced its ...
2025-03-31 18:13
3500
Clinical Study demonstrates Kerry Group Supplement Solution Sensoril® Ashwagandha Supports Quality of Life for Post-Menopausal Women
Sensoril® Ashwagandha is among Kerry's portfolio of solutions tailored to meet
women's unique health needs
SINGAPORE, March 31, 2025 /PRNewswire/ -- Sensoril® ashwagandha
2025-03-31 17:30
3208
Revenue Soars 44%, Basecare Medical (2170.HK) Advances Toward Global Intelligent Manufacturing
SUZHOU, China, March 31, 2025 /PRNewswire/ -- Amid frequent pro-fertility policy updates, Basecare Medical, a pioneer in the assisted reproductive IVD sector with full fertility health industry chain coverage, released its stellar 2024 performance report. The company achieved annual revenue of ne...
2025-03-31 17:01
4843
Reaffirming Leadership: Medit's Strong Presence at IDS 2025
COLOGNE, Germany and SEOUL, South Korea, March 31, 2025 /PRNewswire/ -- Medit, a global leader in digital dentistry solutions, made a significant impact at International Dental (IDS) 2025 by unveiling its latest innovations in intraoral scanning and comprehensive digital workflows. Alongside new ...
2025-03-31 15:00
3312
S Spine Hospital Launches T-Shirt to Raise Awareness About Back Pain
BANGKOK, March 31, 2025 /PRNewswire/ -- S Spine Hospital, a specialist in
spine, has unveiled "THE SPINE T-SHIRT," a health communication initiative
designed to transform how people perceive and understand spinal health issues.
2025-03-31 14:52
2041
Ceva Animal Health renews its shareholding structure with all its long-standing partners and opens its capital to Mérieux Institute and ARCHIMED to accelerate its growth.
LIBOURNE, France, March 31, 2025 /PRNewswire/ -- Ceva Animal Health
2025-03-31 14:12
3356
Acer Medical Debuts VeriSee AI-assisted Screening Solutions at the Malaysian Ophthalmology Society Annual Congress
Collaboration with Intel® for AI-powered medical screening optimizations TAIPEI, March 31, 2025 /PRNewswire/ -- Acer Medical has recently launched its AI-assisted screening software, VeriSee Diabetic Retinopathy and VeriSee Age-Related Macular Degeneration. These innovative solutions will be show...
2025-03-31 11:32
2940
Smartee Pioneers a New Phase in Orthodontics with Silicon Valley Founder Mode
SHANGHAI, March 30, 2025 /PRNewswire/ -- As the clear aligner business enters the second quarter of 2025, it shows a promising growth trend. With increasing competition and innovation in the market, Smartee Denti-Technology remains committed to its "Founder Mode," aiming to seize new business opp...
2025-03-31 10:59
2532
Innovent Receives NMPA Breakthrough Therapy Designation for IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Melanoma
SAN FRANCISCO and SUZHOU, China, March 31, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmun...
2025-03-31 09:22
3378
Human Frontier Science Program: Fellowships Awarded to 60 Pioneering Postdoctoral Scientists from 25 Nations
STRASBOURG, France, March 31, 2025 /PRNewswire/ -- To foster the next
generation of life science research, 60 of the world's top emerging scientists
from 25 nations have won 2025 Human Frontier Science Program (HFSP) Fellowships.
2025-03-31 08:00
2198
Week's Top Stories
Most Reposted
Tetra Pak Opens Product Development Centre in Thailand, Unlocking A World of Possibilities for Food and Beverage Innovators Across Asia Pacific
[Picked up by 327 media titles]
2026-03-27 11:15
UFO SIM Launches in Australia, The Ultimate Travel eSIM Starting at Just AU$2/GB
[Picked up by 310 media titles]
2026-04-01 11:03
Surfin Meta Digital Technology signs MOU with the Philippine Social Security System to explore digital financial service enhancements
[Picked up by 304 media titles]
2026-04-01 09:00
From Doomscroll to Page-Turner: BookXcess Launches The Brain Un-Rot Library to Help Rebuild a Generation's Focus
[Picked up by 301 media titles]
2026-03-31 13:53
Indonesia's P2P Lending Grows 25%, JULO Strengthens Credit Quality
[Picked up by 300 media titles]
2026-03-26 18:18
